682 related articles for article (PubMed ID: 21307941)
1. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
3. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population.
Akan G; Kisenge P; Sanga TS; Mbugi E; Adolf I; Turkcan MK; Janabi M; Atalar F
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):33-43. PubMed ID: 31472045
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes on 9p21 modify the risk for coronary artery disease among Indians.
AshokKumar M; Emmanuel C; Dhandapany PS; Rani DS; SaiBabu R; Cherian KM; Thangaraj K
DNA Cell Biol; 2011 Feb; 30(2):105-10. PubMed ID: 20858033
[TBL] [Abstract][Full Text] [Related]
5. CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI.
Zivotić I; Djurić T; Stanković A; Milasinovic D; Stankovic G; Dekleva M; Marković Nikolić N; Alavantić D; Zivković M
Clin Biochem; 2019 Nov; 73():70-76. PubMed ID: 31386834
[TBL] [Abstract][Full Text] [Related]
6. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease.
Shen GQ; Li L; Rao S; Abdullah KG; Ban JM; Lee BS; Park JE; Wang QK
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):360-5. PubMed ID: 18048766
[TBL] [Abstract][Full Text] [Related]
7. The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.
Chen SN; Ballantyne CM; Gotto AM; Marian AJ
BMC Cardiovasc Disord; 2009 Jan; 9():3. PubMed ID: 19173706
[TBL] [Abstract][Full Text] [Related]
8. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
Visel A; Zhu Y; May D; Afzal V; Gong E; Attanasio C; Blow MJ; Cohen JC; Rubin EM; Pennacchio LA
Nature; 2010 Mar; 464(7287):409-12. PubMed ID: 20173736
[TBL] [Abstract][Full Text] [Related]
10. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
[TBL] [Abstract][Full Text] [Related]
11. The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease.
Temel ŞG; Ergören MÇ
Anatol J Cardiol; 2019 Jan; 21(1):31-38. PubMed ID: 30587704
[TBL] [Abstract][Full Text] [Related]
12. 9p21.3 coronary artery disease risk locus and interferon alpha 21: Association study in an Asian Indian population.
Kalpana B; Murthy DK; Balakrishna N
Indian Heart J; 2019; 71(6):476-480. PubMed ID: 32248921
[TBL] [Abstract][Full Text] [Related]
13. Association of rs10811656 on 9P21.3 with the risk of coronary artery disease in a Chinese population.
Yan J; Zeng J; Xie Z; Liu D; Wang L; Chen Z
Lipids Health Dis; 2016 Aug; 15(1):126. PubMed ID: 27507036
[TBL] [Abstract][Full Text] [Related]
14. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons.
Erridge C; Gracey J; Braund PS; Samani NJ
J Am Coll Cardiol; 2013 Oct; 62(15):1376-81. PubMed ID: 23933542
[TBL] [Abstract][Full Text] [Related]
15. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
Hannou SA; Wouters K; Paumelle R; Staels B
Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
[TBL] [Abstract][Full Text] [Related]
16. The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues.
Pilbrow AP; Folkersen L; Pearson JF; Brown CM; McNoe L; Wang NM; Sweet WE; Tang WH; Black MA; Troughton RW; Richards AM; Franco-Cereceda A; Gabrielsen A; Eriksson P; Moravec CS; Cameron VA
PLoS One; 2012; 7(6):e39574. PubMed ID: 22768093
[TBL] [Abstract][Full Text] [Related]
17. Potential Signals of Natural Selection in the Top Risk Loci for Coronary Artery Disease: 9p21 and 10q11.
Zanetti D; Carreras-Torres R; Esteban E; Via M; Moral P
PLoS One; 2015; 10(8):e0134840. PubMed ID: 26252781
[TBL] [Abstract][Full Text] [Related]
18. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
19. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the 9p21.3 CAD risk locus in Asian Indians.
Shanker J; Arvind P; Jambunathan S; Nair J; Kakkar V
Thromb Haemost; 2014 May; 111(5):960-9. PubMed ID: 24452806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
